Headlines about Integer (NYSE:ITGR) have trended somewhat positive recently, Accern Sentiment reports. The research group scores the sentiment of news coverage by reviewing more than 20 million news and blog sources. Accern ranks coverage of public companies on a scale of negative one to one, with scores closest to one being the most favorable. Integer earned a daily sentiment score of 0.10 on Accern’s scale. Accern also assigned press coverage about the medical equipment provider an impact score of 43.632028942536 out of 100, meaning that recent news coverage is somewhat unlikely to have an effect on the company’s share price in the immediate future.
A number of analysts have recently weighed in on the stock. Northcoast Research lowered shares of Integer from a “buy” rating to a “neutral” rating in a report on Monday, October 23rd. They noted that the move was a valuation call. TheStreet upgraded shares of Integer from a “c+” rating to a “b-” rating in a report on Wednesday, October 18th. BidaskClub upgraded shares of Integer from a “buy” rating to a “strong-buy” rating in a report on Thursday, September 28th. Royal Bank of Canada reiterated a “hold” rating and set a $40.00 target price on shares of Integer in a report on Friday, September 22nd. Finally, KeyCorp reiterated an “overweight” rating and set a $62.00 target price (up from $51.00) on shares of Integer in a report on Monday, September 18th. Four investment analysts have rated the stock with a hold rating and three have assigned a buy rating to the stock. The stock presently has an average rating of “Hold” and an average target price of $51.00.
Shares of Integer (NYSE ITGR) traded down $0.55 on Friday, reaching $48.55. 62,857 shares of the company’s stock traded hands, compared to its average volume of 136,717. The company has a quick ratio of 1.37, a current ratio of 2.58 and a debt-to-equity ratio of 1.95. Integer has a twelve month low of $29.40 and a twelve month high of $55.20. The stock has a market capitalization of $1,554.99, a price-to-earnings ratio of 18.05, a PEG ratio of 1.03 and a beta of 1.08.
Integer (NYSE:ITGR) last issued its quarterly earnings data on Thursday, October 26th. The medical equipment provider reported $0.82 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $0.78 by $0.04. Integer had a net margin of 1.42% and a return on equity of 11.22%. The business had revenue of $363.31 million during the quarter, compared to analyst estimates of $354.83 million. During the same period last year, the business posted $0.83 earnings per share. Integer’s quarterly revenue was up 4.8% compared to the same quarter last year. analysts anticipate that Integer will post 2.62 earnings per share for the current fiscal year.
In other Integer news, insider Declan Smyth sold 1,112 shares of the firm’s stock in a transaction that occurred on Wednesday, January 3rd. The shares were sold at an average price of $44.89, for a total transaction of $49,917.68. Following the completion of the transaction, the insider now owns 11,656 shares of the company’s stock, valued at $523,237.84. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CFO Gary J. Haire sold 731 shares of the firm’s stock in a transaction that occurred on Wednesday, January 3rd. The shares were sold at an average price of $44.89, for a total transaction of $32,814.59. Following the transaction, the chief financial officer now directly owns 1,911 shares of the company’s stock, valued at approximately $85,784.79. The disclosure for this sale can be found here. Insiders sold 100,625 shares of company stock valued at $4,694,219 over the last 90 days. 4.80% of the stock is currently owned by company insiders.
WARNING: “Somewhat Favorable Media Coverage Somewhat Unlikely to Impact Integer (ITGR) Share Price” was reported by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are reading this piece of content on another site, it was copied illegally and republished in violation of US & international trademark & copyright law. The correct version of this piece of content can be viewed at https://www.dispatchtribunal.com/2018/01/13/somewhat-positive-press-coverage-somewhat-unlikely-to-affect-integer-itgr-stock-price.html.
Integer Company Profile
Greatbatch, Inc is a developer and manufacturer of medical devices and components. The Company operates through two segments: Greatbatch Medical and QiG Group (QiG). Greatbatch Medical designs and manufactures products where the Company either owns the intellectual property or has unique manufacturing and assembly expertise.
Receive News & Ratings for Integer Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Integer and related companies with MarketBeat.com's FREE daily email newsletter.